Biotech firm Checkerspot has announced the close of a $55 million Series C financing led by ArrowMark Partners, with participation from Cox Enterprises and other new and existing investors. The funding is supposed to accelerate Checkerspot’s development and commercialization of high-performance, bio-based alternatives for everyday products and to boost Checkerspot’s ...
Or sign-up for a trial month for just 9,90€. To continue reading this article REGISTER NOW.